Meet Dr Nada Melhem – Coalition representative to the ACT-Accelerator Therapeutics Partnership
Following the coalition’s efforts to increase the representation of researchers from low- and middle-income countries in the ACT-Accelerator Therapeutics Partnership, four coalition members have joined its workstreams. Meet Dr Nada Melhem, from the American University of Beirut in Lebanon, who joined workstream 1 which focuses on rapid evidence assessment of therapeutic candidates.
Building community trust for COVID-19 vaccine confidence and deployment
This third webinar in a series on vaccines by the coalition’s Social Science Working Group brought together experts to discuss issues related to research on vaccines and deployment during COVID-19 pandemic and past epidemics and share lessons learned for building trust to improve COVID-19 vaccination uptake.
Setting up biorepositiories and increasing sequencing capacity to respond to SARS-CoV-2 in LMICs
The Virology, Immunology and Diagnostics Working Group organized a webinar to discuss the role of biorepositories and efforts underway to increase COVID-19 sample preservation and storage, as well as the sequencing capacity in LMICs and strategies for increasing it.
COVID-19 research priorities in maternal, reproductive, and child health
The coalition’s Maternal, Newborn, and Child Health Working Group conducted a research priority-setting exercise to identify global research priorities in maternal, reproductive and child health. Members of the working group shared the results in this webinar.
Operational experience for COVID-19 vaccine trials: Lessons from the field
This webinar, the second in a series on social science research related to vaccine trials, brought together social science and community engagement experts to draw on their experiences from clinical trials during COVID-19 and past epidemics.